Compounds > temozolomide
Page last updated: 2024-08-16

temozolomide and tubastatin a

temozolomide has been researched along with tubastatin a in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, BD; Chen, L; Li, QZ; Li, WP; Li, ZY; Zhang, C; Zhang, XJ; Zhang, Y1
Castresana, JS; Erausquin, E; Idoate, MA; Meléndez, B; Rey, JA; Urdiciain, A1
Jeon, YH; Kim, GW; Kwon, SH; Lee, DH; Lee, SW; Yeon, SK; Yoo, J1

Other Studies

3 other study(ies) available for temozolomide and tubastatin a

ArticleYear
A novel HDAC6 inhibitor Tubastatin A: Controls HDAC6-p97/VCP-mediated ubiquitination-autophagy turnover and reverses Temozolomide-induced ER stress-tolerance in GBM cells.
    Cancer letters, 2017, 04-10, Volume: 391

    Topics: Autophagy; Dacarbazine; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Indoles; Temozolomide; Transfection; Ubiquitination

2017
Tubastatin A, an inhibitor of HDAC6, enhances temozolomide‑induced apoptosis and reverses the malignant phenotype of glioblastoma cells.
    International journal of oncology, 2019, Volume: 54, Issue:5

    Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glioblastoma; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Phenotype; Temozolomide; Up-Regulation

2019
Temozolomide-resistant Glioblastoma Depends on HDAC6 Activity Through Regulation of DNA Mismatch Repair.
    Anticancer research, 2019, Volume: 39, Issue:12

    Topics: Antineoplastic Agents, Alkylating; Benzene Derivatives; Brain Neoplasms; Cell Line, Tumor; Cell Survival; DNA Mismatch Repair; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; Drug Resistance, Neoplasm; ErbB Receptors; Glioblastoma; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; MutS Homolog 2 Protein; Pyrimidines; Temozolomide; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Up-Regulation

2019